Check the latest share price of Panacea Biotec, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 06 Jun 2025
NSE
Get live Panacea Biotec share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -11.03 % |
3 Month Return | + 19.88 % |
1 Year Return | + 247.3 % |
3 Year Return | + 199.13 % |
5 Year Return | + 179.84 % |
Market Stats | |
Previous Close | ₹471.30 |
Open | ₹471.30 |
Volume | 3.28L |
Upper Circuit | ₹518.40 |
Lower Circuit | ₹424.20 |
Check Panacea Biotec market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹2,740.97 Cr
Return on Equity (ROE)
0.86
PE Ratio (TTM)
-321.94
Return on capital employed (ROCE)
3.26
Industry PE ratio
56.05
Beta (LTM)
1
P/B Ratio
2.42
Dividend Yield
0PEG Ratio
261.74
Quarterly Earnings Growth YOY
0EPS (TTM)
-0.25
Sector
Pharmaceuticals
Book Value
133.94
Technical Analysis
Bearish
View Technical Analysis
Investing in Panacea Biotec is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Panacea Biotec or PANACEABIO on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Panacea Biotec or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Panacea Biotec with just a few clicks!
Track how Panacea Biotec P/E has moved over time to understand its valuation trends.
Panacea Biotec in the last 5 years
Lowest (-915.62x)
April 25, 2024
Today (-321.94x)
June 6, 2025
Industry (56.05x)
June 6, 2025
Highest (113.15x)
October 5, 2023
Today’s Price to Earnings Ratio: -321.94x
Get the annual and quarterly financial summary of Panacea Biotec, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Panacea Biotec.
Panacea Biotec Ltd’s net profit jumped 5.03% since last year same period to ₹-1.89Cr in the Q4 2024-2025. On a quarterly growth basis, Panacea Biotec Ltd has generated -141.81% fall in its net profits since last 3-months.
Read More about Earnings ResultsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Panacea Biotec.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 72.48% | 0.00 | |
Foreign Institutions | 1.16% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 24.86% | 0.00 | |
Others | 1.49% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Panacea Biotec with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 2,740.97 | 35.97% | 0.65 | NA | NA | |
NA | 603.84 | 1703.75% | 0.53 | NA | NA | |
NA | 2,065.52 | 21.1% | 0.51 | NA | NA | |
NA | 93.54 | 130.17% | 2.00 | NA | NA | |
NA | 274.96 | 24.71% | 0.60 | NA | NA |
Latest news and events in one place to help you make informed investing decisions in Panacea Biotec.
Panacea Biotec Develops Promising Dengue Vaccine - 27 May, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
FII Holding Up
Foreign Institutions have increased holdings from 0.38% to 1.16% in Mar 2025 quarter
Best in 3 Years
In the last 3 years, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Down
Promoters have decreased holdings from 72.49% to 72.48% in Mar 2025 quarter
Retail Holding Down
Retail Investor have decreased holdings from 25.97% to 24.86% in Mar 2025 quarter
Price Dip
In the last 7 days, PANACEABIO stock has moved down by -11.2%
Revenue Fall
Revenue is down for the last 2 quarters, 169.88 Cr → 168.83 Cr (in ₹), with an average decrease of 0.6% per quarter
Profit Down
Netprofit is down for the last 3 quarters, 4.8 Cr → -1.89 Cr (in ₹), with an average decrease of 73.8% per quarter
Organisation | Panacea Biotec Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
CEO | Rajesh Jain |
E-voting on shares | Click here to vote |
Panacea Biotec share price today stands at ₹447.5, Open: ₹471.3, Previous Close: ₹471.3, High: ₹475.2, Low: ₹442.6, 52 Week High: ₹581.9, 52 Week Low: ₹112.35.
Today's traded volume of Panacea Biotec is 3.28L. Which means that 3.28L shares of Panacea Biotec were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Panacea Biotec is ₹2,740.97 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Panacea Biotec’s 52 week high is ₹581.9 and 52 week low is ₹112.35. The current share price of Panacea Biotec is ₹447.5, which is -23.10% down from its 52 week high and 298.31% up from its 52 week low.